Stay updated on Emixustat in Stargardt Macular Atrophy Clinical Trial
Sign up to get notified when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.

Latest updates to the Emixustat in Stargardt Macular Atrophy Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated to v3.4.3; previous tag v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 is now displayed, and the funding-status notice along with Revision: v3.4.1 text has been removed.SummaryDifference0.5%

- Check41 days agoChange DetectedA government funding notice about potential delays and site status was added. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a glossary and the 'Last Update Submitted that Met QC Criteria' field, and updated the footer to 'Revision: v3.4.0'; removed the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' items.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4; no impact on study content or page functionality is observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page adds a dedicated Locations section with Texas listed as a site. The older Texas Locations entry has been removed and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Emixustat in Stargardt Macular Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.